WELLNEX LIFE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.029 AUD | +38.10% |
|
+20.83% | +26.09% |
| May. 09 | Wellnex Life Records AU$2 Million in Orders for April; Shares Jump 17% | MT |
| May. 08 | Wellnex Life Expands Wakey Wakey Range with Two New Products | MT |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 227.6 | 98.22 | 129.4 | 122.2 | 20.32 | 22.46 |
| Enterprise Value (EV) 1 | 172.7 | 81.97 | 134 | 123.8 | 25 | 28.84 |
| P/E ratio | -8.78 x | -9.9 x | -2.34 x | -5.14 x | -2.71 x | -1.55 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 144 x | 111 x | 139 x | 102 x | 1.09 x | 0.81 x |
| EV / Revenue | 110 x | 92.4 x | 144 x | 104 x | 1.34 x | 1.03 x |
| EV / EBITDA | -8.82 x | -7.8 x | -14.2 x | -14.3 x | -4.07 x | -3.61 x |
| EV / FCF | 412 x | -3.23 x | -15.2 x | -8.87 x | -3.93 x | -5.08 x |
| FCF Yield | 0.24% | -31% | -6.57% | -11.3% | -25.5% | -19.7% |
| Price to Book | 3.71 x | 1.9 x | 5.83 x | -520 x | 4.66 x | 37.8 x |
| Nbr of stocks (in thousands) | 194,503 | 194,503 | 244,087 | 230,649 | 303,306 | 423,719 |
| Reference price 2 | 1.170 | 0.5050 | 0.5300 | 0.5300 | 0.0670 | 0.0530 |
| Announcement Date | 8/31/18 | 9/20/19 | 12/21/20 | 9/29/21 | 9/30/22 | 11/2/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.575 | 0.887 | 0.934 | 1.195 | 18.61 | 27.88 |
| EBITDA 1 | -19.59 | -10.51 | -9.451 | -8.673 | -6.139 | -7.983 |
| EBIT 1 | -19.6 | -10.52 | -9.458 | -8.684 | -6.208 | -8.15 |
| Operating Margin | -1,244.32% | -1,186.47% | -1,012.63% | -726.69% | -33.36% | -29.24% |
| Earnings before Tax (EBT) 1 | -19.84 | -10.34 | -65.44 | -20.12 | -7.449 | -13.85 |
| Net income 1 | -19.83 | -9.911 | -46.27 | -24.69 | -7.449 | -13.85 |
| Net margin | -1,259.24% | -1,117.36% | -4,953.53% | -2,065.94% | -40.03% | -49.67% |
| EPS 2 | -0.1332 | -0.0510 | -0.2261 | -0.1031 | -0.0247 | -0.0343 |
| Free Cash Flow 1 | 0.4192 | -25.41 | -8.806 | -13.96 | -6.368 | -5.678 |
| FCF margin | 26.62% | -2,865.06% | -942.8% | -1,168.35% | -34.23% | -20.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/31/18 | 9/20/19 | 12/21/20 | 9/29/21 | 9/30/22 | 11/2/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 4.68 | 1.53 | 4.68 | 6.38 |
| Net Cash position 1 | 54.9 | 16.3 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | -0.495 x | -0.1768 x | -0.7619 x | -0.7993 x |
| Free Cash Flow 1 | 0.42 | -25.4 | -8.81 | -14 | -6.37 | -5.68 |
| ROE (net income / shareholders' equity) | -57.9% | -18.3% | -241% | -1,564% | -362% | -559% |
| ROA (Net income/ Total Assets) | -33.9% | -10.7% | -15.2% | -36.6% | -25.8% | -29.4% |
| Assets 1 | 58.51 | 92.47 | 303.7 | 67.43 | 28.83 | 47.09 |
| Book Value Per Share 2 | 0.3200 | 0.2700 | 0.0900 | -0 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.2900 | 0.0900 | 0 | 0.0300 | 0.0100 | 0 |
| Capex 1 | 0.77 | 8.04 | 23.8 | 0.79 | - | - |
| Capex / Sales | 48.89% | 906.31% | 2,544.43% | 66.19% | - | - |
| Announcement Date | 8/31/18 | 9/20/19 | 12/21/20 | 9/29/21 | 9/30/22 | 11/2/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +26.09% | 24.24M | |
| +13.36% | 6.21B | |
| -13.86% | 4.3B | |
| +8.04% | 4.01B | |
| +4.23% | 1.92B | |
| -4.09% | 1.78B | |
| -10.93% | 1.3B | |
| -16.64% | 1.15B | |
| -26.56% | 935M | |
| +5.20% | 671M |
- Stock Market
- Equities
- WNX Stock
- Financials Wellnex Life Limited